IDIBELL – Institut d'Investigació Biomèdica de Bellvitge

Research based at Bellvitge Hospital

Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) is a biomedical research center based at Hospital Duran i Reynals in L'Hospitalet de Llobregat, near Barcelona. Its work is organized into four research areas: cancer, neuroscience, translational medicine, and regenerative medicine.

Research and innovation

IDIBELL combines basic and clinical research with an innovation unit focused on bringing laboratory findings closer to patients. Its work includes health innovation projects and efforts to promote independent clinical trials.

The institute has renewed ISO certifications in three areas: innovation, biological sample management, and promotion of independent clinical trials. It also holds the HRS4R accreditation, recognizing its commitment to continuous improvement in research human-resources management.

Featured programs

• REMMA Bellvitge, described as the first research program in Spain focused on rare diseases in adults.
• IDIBELL seminars, where international researchers share their work.
• For-credit internships and summer internships for students interested in a scientific career.
• A 2026 multiple sclerosis update program.

Training and public engagement

IDIBELL offers science outreach and works with schools, including through the Tàndem IDIBELL-InsBellvitge program. It also publishes public-facing science content and an annual activity report.

Location and contact

Main office: Hospital Duran i Reynals, Edifici Terapèutic, 2nd floor, Av. Gran Via de l'Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain. Phone: +34 93 607 38 00. Email: info@idibell.cat. General email: idibell@idibell.cat. Data protection: dataprotection@idibell.cat.